{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:25:35Z","timestamp":1769271935871,"version":"3.49.0"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Chylomicronemia syndrome is a metabolic condition characterized by severe fasting hypertrigliceridemia (\u22651000 mg\/dL) and other clinical features including chronic abdominal pain and recurrent acute pancreatitis. In patients with acute or recurrent pancreatitis, plasma exchange (PEx) is indicated for the treatment of acute disease and prevention of recurrence. The use of plasma instead of albumin as replacement fluid has been suggested for its putative ability to replace the deficient enzyme possibly leading to better clinical improvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>CASE REPORT<\/jats:title><jats:p>A 40\u2010year\u2010old man with chylomicronemia syndrome due to a newly identified loss\u2010of\u2010function mutation in the lipoprotein lipase (LPL) gene (IVS2, c.250\u20101G\/C) has been treated at our hospital since the age of 13. From age 18 to age 34, the patient had five episodes of acute pancreatitis while his triglyceride (TG) levels were extremely high (2500\u20134000 mg\/dL). As the TG levels remained stable over 4000 mg\/dL despite the maximum medical treatment, the patient started long\u2010term PEx treatment on a weekly basIs. Both albumin and plasma have been used as replacement solution. Thirty months from the beginning of this treatment, no episode of acute pancreatitis has been reported, and the chronic abdominal pain fully disappeared. No differences were observed between the use of albumin or plasma as replacement solution.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>Long\u2010term PEx is effective in preventing the recurrence of acute pancreatitis and in treatment of chronic abdominal pain in this patient with chylomicronemia syndrome. Plasma is not more effective than albumin in lipid reduction, likely because of its extremely low enzyme content. Therefore, in patients with LPL deficiency serum albumin should be preferred to plasma as replacement fluid because of the low rate of side effects and reduced costs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.13400","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T14:00:07Z","timestamp":1446645607000},"page":"755-760","source":"Crossref","is-referenced-by-count":8,"title":["Albumin versus solvent\/detergent\u2013treated pooled plasma as replacement fluid for long\u2010term plasma exchange therapy in a patient with primary hypertriglyceridemia and recurrent hyperlipidemic pancreatitis"],"prefix":"10.1111","volume":"56","author":[{"given":"Danilo","family":"Di Bona","sequence":"first","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"},{"name":"Sezione di Patologia Generale, Dipartimento di Biopatologia e Biotecnologie Mediche, Universit\u00e0 di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo B.","family":"Cefal\u00f9","sequence":"additional","affiliation":[{"name":"Dipartimento BioMedico di Medicina Interna e Specialistica Universit\u00e0 Degli Studi di Palermo Palermo Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Scir\u00e8","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo M.","family":"Lima","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Maria","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonina","family":"Giammanco","sequence":"additional","affiliation":[{"name":"Dipartimento BioMedico di Medicina Interna e Specialistica Universit\u00e0 Degli Studi di Palermo Palermo Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo M.","family":"Barbagallo","sequence":"additional","affiliation":[{"name":"Dipartimento BioMedico di Medicina Interna e Specialistica Universit\u00e0 Degli Studi di Palermo Palermo Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio R.","family":"Averna","sequence":"additional","affiliation":[{"name":"Dipartimento BioMedico di Medicina Interna e Specialistica Universit\u00e0 Degli Studi di Palermo Palermo Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calogero","family":"Caruso","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa di Medicina Trasfusionale Azienda Ospedaliera Universitaria Policlinico di Palermo"},{"name":"Sezione di Patologia Generale, Dipartimento di Biopatologia e Biotecnologie Mediche, Universit\u00e0 di Palermo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198905113201910"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1989.tb00255.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197806082982301"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114769"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000153087.36428.dd"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24471"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.186577"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R009720"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.1999.00158.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.10047"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006676-199607000-00013"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20224"},{"key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/jcem.87.1.8176","article-title":"Intensive, long\u2010term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy","volume":"87","author":"Bolan C","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.04.815"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0022-2275(20)36948-0","article-title":"Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol\u2010rich lipoproteins","volume":"34","author":"Vilella E","year":"1993","journal-title":"J Lipid Res"},{"key":"e_1_2_6_17_1","volume-title":"R: a language and environment for statistical computing","author":"Ref. R Development Core Team.","year":"2009"},{"key":"e_1_2_6_18_1","first-page":"249","article-title":"Chylomicronemia syndrome","volume":"37","author":"Chait A","year":"1992","journal-title":"Adv Intern Med"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/diab.37.5.610","article-title":"Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation","volume":"37","author":"Eckel RH","year":"1988","journal-title":"Diabetes"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2012.43"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21276"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)37569-6"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13400","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.13400","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.13400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T14:13:21Z","timestamp":1695046401000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.13400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1111\/trf.13400"],"URL":"https:\/\/doi.org\/10.1111\/trf.13400","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}